Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

A Mixed-Methods Study Examining Adherence to and Acceptability of Intravaginal Rings for HIV Prevention: Behavioral Results of MTN-027.

Bauermeister JA, Golinkoff JM, Carballo-Diéguez A, Giguere R, López D, Hoesley CJ, Chen BA, Anderson P, Dezzutti CS, Strizki J, Sprinkle C, Heard F, Hall W, Jacobson C, Berthiaume J, Mayo A, Richardson BA, Piper J; Microbicide Trials Network 027 Study Team.

AIDS Behav. 2019 Mar 15. doi: 10.1007/s10461-019-02457-0. [Epub ahead of print]

PMID:
30877580
2.

Pharmacokinetics of Dapivirine Transfer into Blood Plasma, Breast Milk, and Cervicovaginal Fluid of Lactating Women Using the Dapivirine Vaginal Ring.

Noguchi LM, Hoesley C, Kelly C, Scheckter R, Bunge K, Nel A, Marzinke MA, Hendrix CW, Dezzutti CS, Hillier SL, Bogen DL, Piper JM, Beigi RH.

Antimicrob Agents Chemother. 2019 Feb 26;63(3). pii: e01930-18. doi: 10.1128/AAC.01930-18. Print 2019 Mar.

3.

Improvement of gram-negative susceptibility to fluoroquinolones after implementation of a pre-authorization policy for fluoroquinolone use: A decade-long experience.

Lee RA, Scully MC, Camins BC, Griffin RL, Kunz DF, Moser SA, Hoesley CJ, McCarty TP, Pappas PG.

Infect Control Hosp Epidemiol. 2018 Dec;39(12):1419-1424. doi: 10.1017/ice.2018.245. Epub 2018 Oct 9.

PMID:
30296959
4.

Phase 2a Safety, Pharmacokinetics, and Acceptability of Dapivirine Vaginal Rings in US Postmenopausal Women.

Chen BA, Zhang J, Gundacker HM, Hendrix CW, Hoesley CJ, Salata RA, Dezzutti CS, van der Straten A, Hall WB, Jacobson CE, Johnson S, McGowan I, Nel AM, Soto-Torres L, Marzinke MA; MTN-024/IPM 031 Protocol Team for the Microbicide Trials Network .

Clin Infect Dis. 2019 Mar 19;68(7):1144-1151. doi: 10.1093/cid/ciy654.

PMID:
30289485
5.

Phase 1 Safety and Pharmacokinetics Study of MK-2048/Vicriviroc (MK-4176)/MK-2048A Intravaginal Rings.

Hoesley CJ, Chen BA, Anderson PL, Dezzutti CS, Strizki J, Sprinkle C, Heard F, Bauermeister J, Hall W, Jacobson C, Berthiaume J, Mayo A, Gundacker H, Richardson-Harman N, Piper J; Microbicide Trials Network 027 Study Team.

Clin Infect Dis. 2019 Mar 19;68(7):1136-1143. doi: 10.1093/cid/ciy653.

PMID:
30289435
6.

Adherence and Acceptability of a Multidrug Vaginal Ring for HIV Prevention in a Phase I Study in the United States.

van der Straten A, Panther L, Laborde N, Hoesley CJ, Cheng H, Husnik MJ, Horn S, Nel A, Soto-Torres L, Chen BA.

AIDS Behav. 2016 Nov;20(11):2644-2653.

7.

First-in-Human Trial of MIV-150 and Zinc Acetate Coformulated in a Carrageenan Gel: Safety, Pharmacokinetics, Acceptability, Adherence, and Pharmacodynamics.

Friedland BA, Hoesley CJ, Plagianos M, Hoskin E, Zhang S, Teleshova N, Alami M, Novak L, Kleinbeck KR, Katzen LL, Zydowsky TM, Fernández-Romero JA, Creasy GW.

J Acquir Immune Defic Syndr. 2016 Dec 15;73(5):489-496.

8.

Pharmacodynamic correlations using fresh and cryopreserved tissue following use of vaginal rings containing dapivirine and/or maraviroc in a randomized, placebo controlled trial.

Dezzutti CS, Richardson-Harman N, Rohan LC, Marzinke MA, Hoesley CJ, Panther L, Johnson S, Nuttall JP, Nel A, Chen BA; Microbicide Trials Network, MTN-013IPM 026 Protocol Team.

Medicine (Baltimore). 2016 Jul;95(28):e4174. doi: 10.1097/MD.0000000000004174.

9.

In Vitro Exposure to PC-1005 and Cervicovaginal Lavage Fluid from Women Vaginally Administered PC-1005 Inhibits HIV-1 and HSV-2 Infection in Human Cervical Mucosa.

Villegas G, Calenda G, Zhang S, Mizenina O, Kleinbeck K, Cooney ML, Hoesley CJ, Creasy GW, Friedland B, Fernández-Romero JA, Zydowsky TM, Teleshova N.

Antimicrob Agents Chemother. 2016 Aug 22;60(9):5459-66. doi: 10.1128/AAC.00392-16. Print 2016 Sep.

10.

Evaluation of baseline corrected QT interval and azithromycin prescriptions in an academic medical center.

Lee RA, Guyton A, Kunz D, Cutter GR, Hoesley CJ.

J Hosp Med. 2016 Jan;11(1):15-20. doi: 10.1002/jhm.2448. Epub 2015 Aug 19.

PMID:
26287278
11.

Phase 1 Safety, Pharmacokinetics, and Pharmacodynamics of Dapivirine and Maraviroc Vaginal Rings: A Double-Blind Randomized Trial.

Chen BA, Panther L, Marzinke MA, Hendrix CW, Hoesley CJ, van der Straten A, Husnik MJ, Soto-Torres L, Nel A, Johnson S, Richardson-Harman N, Rabe LK, Dezzutti CS.

J Acquir Immune Defic Syndr. 2015 Nov 1;70(3):242-9. doi: 10.1097/QAI.0000000000000702.

12.

Correction: Musosal effects for tenofovir 1% gel.

Hladik F, Burgener A, Ballweber L, Gottardo R, Vojtech L, Fourati S, Dai JY, Cameron MJ, Strobl J, Hughes SM, Hoesley C, Andrew P, Johnson S, Piper J, Friend DR, Ball TB, Cranston RD, Mayer KH, McElrath MJ, McGowan I.

Elife. 2015 Mar 24;4. doi: 10.7554/eLife.07586. No abstract available.

13.

Mucosal effects of tenofovir 1% gel.

Hladik F, Burgener A, Ballweber L, Gottardo R, Vojtech L, Fourati S, Dai JY, Cameron MJ, Strobl J, Hughes SM, Hoesley C, Andrew P, Johnson S, Piper J, Friend DR, Ball TB, Cranston RD, Mayer KH, McElrath MJ, McGowan I.

Elife. 2015 Feb 3;4. doi: 10.7554/eLife.04525. Erratum in: Elife. 2015;4. doi: 10.7554/eLife.07586.

14.

Barrier methods for human immunodeficiency virus prevention.

Eaton EF, Hoesley CJ.

Infect Dis Clin North Am. 2014 Dec;28(4):585-99. doi: 10.1016/j.idc.2014.08.006. Epub 2014 Nov 20. Review.

PMID:
25455315
15.

Integration of gross anatomy in an organ system-based medical curriculum: strategies and challenges.

Brooks WS, Woodley KT, Jackson JR, Hoesley CJ.

Anat Sci Educ. 2015 May-Jun;8(3):266-74. doi: 10.1002/ase.1483. Epub 2014 Aug 6.

PMID:
25132664
16.

A randomized male tolerance study of dapivirine gel following multiple topical penile exposures (MTN 012/IPM 010).

Cranston RD, Hoesley C, Carballo-Diéguez A, Hendrix CW, Husnik M, Levy L, Hall W, Soto-Torres L, Nel AM.

AIDS Res Hum Retroviruses. 2014 Feb;30(2):184-9. doi: 10.1089/AID.2013.0170. Epub 2013 Oct 26.

17.

A phase 1 randomized, double blind, placebo controlled rectal safety and acceptability study of tenofovir 1% gel (MTN-007).

McGowan I, Hoesley C, Cranston RD, Andrew P, Janocko L, Dai JY, Carballo-Dieguez A, Ayudhya RK, Piper J, Hladik F, Mayer K.

PLoS One. 2013;8(4):e60147. doi: 10.1371/journal.pone.0060147. Epub 2013 Apr 3.

18.

MTN-001: randomized pharmacokinetic cross-over study comparing tenofovir vaginal gel and oral tablets in vaginal tissue and other compartments.

Hendrix CW, Chen BA, Guddera V, Hoesley C, Justman J, Nakabiito C, Salata R, Soto-Torres L, Patterson K, Minnis AM, Gandham S, Gomez K, Richardson BA, Bumpus NN.

PLoS One. 2013;8(1):e55013. doi: 10.1371/journal.pone.0055013. Epub 2013 Jan 30.

19.

Adherence and acceptability in MTN 001: a randomized cross-over trial of daily oral and topical tenofovir for HIV prevention in women.

Minnis AM, Gandham S, Richardson BA, Guddera V, Chen BA, Salata R, Nakabiito C, Hoesley C, Justman J, Soto-Torres L, Patterson K, Gomez K, Hendrix CW.

AIDS Behav. 2013 Feb;17(2):737-47. doi: 10.1007/s10461-012-0333-8.

20.

University of Alabama School of Medicine.

Evans H, Hoesley C.

Acad Med. 2010 Sep;85(9 Suppl):S69-73. doi: 10.1097/ACM.0b013e3181e8684f. No abstract available.

PMID:
20736652
21.

Anal-rectal cytology: correlation with human papillomavirus status and biopsy diagnoses in a population of HIV-positive patients.

Bean SM, Chhieng DC, Roberson J, Raper JL, Broker TR, Hoesley CJ, Eltoum IA, Jin G.

J Low Genit Tract Dis. 2010 Apr;14(2):90-6. doi: 10.1097/LGT.0b013e3181ba9bcd.

PMID:
20354415
23.

Novel methodology for antiretroviral quantitation in the female genital tract.

Bennetto-Hood C, Johnson VA, King JR, Hoesley CJ, Acosta EP.

HIV Clin Trials. 2009 May-Jun;10(3):193-9. doi: 10.1310/hct1003-193.

24.

Internal medicine clerkship characteristics associated with enhanced student examination performance.

Griffith CH 3rd, Wilson JF, Haist SA, Albritton TA, Bognar BA, Cohen SJ, Hoesley CJ, Fagan MJ, Ferenchick GS, Pryor OW, Friedman E, Harrell HE, Hemmer PA, Houghton BL, Kovach R, Lambert DR, Loftus TH, Painter TD, Udden MM, Watkins RS, Wong RY.

Acad Med. 2009 Jul;84(7):895-901. doi: 10.1097/ACM.0b013e3181a82013.

PMID:
19550183
25.

Emergence of USA300 MRSA in a tertiary medical centre: implications for epidemiological studies.

Patel M, Waites KB, Hoesley CJ, Stamm AM, Canupp KC, Moser SA.

J Hosp Infect. 2008 Mar;68(3):208-13. doi: 10.1016/j.jhin.2007.12.010. Epub 2008 Mar 4.

PMID:
18289726
26.

Dissemination of community-associated methicillin-resistant Staphylococcus aureus in a tertiary care hospital.

Patel M, Hoesley CJ, Moser SA, Stamm AM, Baddley JW, Waites KB.

South Med J. 2008 Jan;101(1):40-5. doi: 10.1097/SMJ.0b013e31815d3fce.

PMID:
18176290
27.

USA300 genotype community-associated methicillin-resistant Staphylococcus aureus as a cause of surgical site infections.

Patel M, Kumar RA, Stamm AM, Hoesley CJ, Moser SA, Waites KB.

J Clin Microbiol. 2007 Oct;45(10):3431-3. Epub 2007 Aug 1.

28.

Nosocomial spread of Enterococcus faecium resistant to vancomycin and linezolid in a tertiary care medical center.

Dobbs TE, Patel M, Waites KB, Moser SA, Stamm AM, Hoesley CJ.

J Clin Microbiol. 2006 Sep;44(9):3368-70.

29.

Prevalence of inducible clindamycin resistance among community- and hospital-associated Staphylococcus aureus isolates.

Patel M, Waites KB, Moser SA, Cloud GA, Hoesley CJ.

J Clin Microbiol. 2006 Jul;44(7):2481-4.

30.

Safety and acceptability of cellulose sulfate as a vaginal microbicide in HIV-infected women.

El-Sadr WM, Mayer KH, Maslankowski L, Hoesley C, Justman J, Gai F, Mauck C, Absalon J, Morrow K, Mâsse B, Soto-Torres L, Kwiecien A.

AIDS. 2006 May 12;20(8):1109-16.

PMID:
16691061
32.

Trends in AIDS-defining and non-AIDS-defining malignancies among HIV-infected patients: 1989-2002.

Bedimo R, Chen RY, Accortt NA, Raper JL, Linn C, Allison JJ, Dubay J, Saag MS, Hoesley CJ.

Clin Infect Dis. 2004 Nov 1;39(9):1380-4. Epub 2004 Oct 11.

PMID:
15494916
33.

Incidence and risk factors for sexually transmitted infections among women in an Alabama HIV clinic.

Monteiro CA, Bachmann LH, Desmond RA, Squires KE, Vermund SH, Hook EW, Schwebke JR, Hoesley CJ.

AIDS Res Hum Retroviruses. 2004 Jun;20(6):577-83.

PMID:
15242532
34.

University of alabama school of medicine.

Sims R, Weaver B, Caldwell J, Allman R, Pillion D, Massie FS Jr, Hoesley C, Peel C, Turner T, Duxbury A, Woodby L, Meleth R, Boulware D, Thompson P.

Acad Med. 2004 Jul;79(7 Suppl):S1-2. No abstract available.

PMID:
15240206
35.

A prospective study of genital herpes simplex virus type 2 infection in human immunodeficiency virus type 1 (HIV-1)-seropositive women: correlations with CD4 cell count and plasma HIV-1 RNA level.

Wright PW, Hoesley CJ, Squires KE, Croom-Rivers A, Weiss HL, Gnann JW Jr.

Clin Infect Dis. 2003 Jan 15;36(2):207-11. Epub 2003 Jan 6.

PMID:
12522754
36.

Comparative analysis of commercial assays for the detection and quantification of Human Immunodeficiency Virus Type 1 (HIV-1) RNA in plasma from patients infected with HIV-1 subtype C.

Hoesley CJ, Allen SA, Raper JL, Musonda R, Niu Y, Gao F, Squires KE, Aldrovandi GM.

Clin Infect Dis. 2002 Aug 1;35(3):323-5. Epub 2002 Jul 9.

PMID:
12115099
37.

Viral latency--the papillomavirus model.

Broker TR, Jin G, Croom-Rivers A, Bragg SM, Richardson M, Chow LT, Vermund SH, Alvarez RD, Pappas PG, Squires KE, Hoesley CJ.

Dev Biol (Basel). 2001;106:443-51; discussion 452-3, 465-75.

PMID:
11761260
38.
39.

Endocarditis at the millennium.

Hoesley CJ, Cobbs CG.

J Infect Dis. 1999 Mar;179 Suppl 2:S360-5. Review.

PMID:
10081508
40.

Use of statistics and scientific inference: odds ratios, likelihood ratio, and receiving operating characteristic curves.

Hoesley C, Centor RM, Heudebert GR.

J Infect Dis. 1998 Sep;178(3):921-3. No abstract available.

PMID:
9728576

Supplemental Content

Loading ...
Support Center